ArticleMolecules (Basel, Switzerland)2019
Supramolecular Detection of a Nerve Agent Simulant by Fluorescent Zn-Salen Oligomer Receptors.
Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 26 citations in OpenAlex.
- Sensing of human stress biomarkers using BODIPY-functionalized carbon nanoparticles.Frontiers in chemistry · 2026Article
- A New BODIPY-Based Receptor for the Fluorescent Sensing of Catecholamines.Molecules (Basel, Switzerland) · 2024Article
- Article
- Agile Detection of Chemical Warfare Agents by Machine Vision: a Supramolecular Approach.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- Light-up photoluminescence sensing of a nerve agent simulant by a bis-porphyrin-salen-UORSC advances · 2021Article
- Supramolecular Sensing of a Chemical Warfare Agents Simulant by Functionalized Carbon Nanoparticles.Molecules (Basel, Switzerland) · 2020Article
- Enantiomeric Recognition of α-Aminoacids by a Uranyl Salen-Bis-Porphyrin Complex.Frontiers in chemistry · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report on new Zn-Salen oligomer receptors able to recognize a nerve agent simulant, namely dimethyl methylphosphonate (DMMP), by a supramolecular approach. In particular, three Zn-Salen oligomers (Zn-Oligo-A, -B, and -C), differing by the length distribution, were obtained and characterized by NMR, Gel Permeation Chromatography (GPC), UV-Vis, and fluorescence spectroscopy. Furthermore, we investigated their recognition properties towards DMMP by using fluorescence measurements. We found that the recognition ability depends on the length of the oligomeric chain, and the Zn-Oligo-C shows a binding constant value higher than those already reported in literature for the DMMP detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.